Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium

Cardiovascular Pathology

Volumn 16, Issue 2, 2007, Pages 63-68

  Bougioukas, Ioannis ^a   Didilis, Vassilios ^a   Ypsilantis, Petros ^a   Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Lialiaris, Theodoros ^a   Mikroulis, Dimitrios ^a   Simopoulos, Constantinos ^a   Bougioukas, Georgios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Angiogenesis; Experimental; Myocardial infarction

Indexed keywords

ALKALINE PHOSPHATASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JC70; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR 1; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR 2; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR 165 PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; HEART INFARCTION; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RABBIT; THORACOTOMY;

ANIMALS; BIOLOGICAL MARKERS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEART; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRALESIONAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847079556     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.08.006     Document Type: Article

References (38)

1. Harada K., Friedman M., Lopez J., Wang S., Li J., Prasad P., et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270 5 Pt 2 (1996) H1791-H1802
2. Kawasuji M., Nagamine H., Ikeda M., Sakakibara N., Takemura H., Fujii S., and Watanabe Y. Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor. Ann Thorac Surg 69 4 (2000) 1155-1161
3. Hughes G., Biswas S., Yin B., Coleman R., DeGrado T., Landolfo C., et al. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. Ann Thorac Surg 77 3 (2004) 812-818
4. Liu Y., Sun L., Huan Y., Zhao H., Ge Y., and Gao F. The effect of basic fibroblast growth factor on angiogenesis and on the expression of basic fibroblast growth factor and vascular endothelial growth factor in acute infarcted myocardium. Zhonghua Yi Xue Za Zhi 84 1 (2004) 54-57
5. Sellke F., Laham R., Edelman E., Pearlman J., and Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 65 6 (1998) 1540-1544
6. Henry T., Annex B., McKendall G., Azrin M., Lopez J., Giordano F., et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107 10 (2003) 1359-1365
7. Floege J., Kriz W., Schulze M., Susani M., Kerjaschki D., Mooney A., et al. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 96 6 (1995) 2809-2819
8. Hariawala M., Horowitz J., Esakof D., Sheriff D., Walter D., Keyt B., et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63 (1996) 77-82
9. Sasaki T., Jyo Y., Tanda N., Kawakami Y., Nohno T., Tamai H., et al. Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy. Kidney Int 51 1 (1997) 301-309
10. Baumgartner I., Rauh G., Pieczek A., Wuensch D., Magner M., Kearney M., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 132 11 (2000) 880-884
11. Lee R., Springer M., Blanco-Bose W., Shaw R., Ursell P., and Blau H. VEGF gene delivery to myocardium. Deleterious effects of unregulated expression. Circulation 102 8 (2000) 898-901
12. Schwarz E., Speakman M., Patterson M., Hale S., Isner J., Kedes L., et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol 35 5 (2000) 1323-1330
13. Li Y., Ma Y., Sun L., Gang H., Guang X., Sun M., et al. Preliminary study on promoting angiogenesis of coronary artery with self-made recombinant human basic fibroblast growth factor. Chin Med J 114 3 (2001) 235-239 [netprints]
14. Miyataka M., Ishikawa K., and Katori R. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs. Angiology 49 5 (1998) 381-390
15. Connolly D., Heuvelman D., Nelson R., Olander J., Eppley B., Delfino J., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84 5 (1989) 1470-1478
16. Ferrara N., Houck K., Jakeman L., and Leung D. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 1 (1992) 18-32
17. Carmeliet P., and Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol 273 5 Pt 2 (1997) H2091-H2104
18. Fong G., Rossant J., Gertsenstein M., and Breitman M. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 6535 (1995) 66-70
19. Montesano R., Vassalli J., Baird A., Guillemin R., and Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 83 19 (1986) 7297-7301
20. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 (1987) 442-447
21. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 4 (2000) 389-395
22. Seko Y., Imai Y., Suzuki S., Kamijukkoku S., Hayasaki K., Sakomura Y., et al. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci (Lond) 92 5 (1997) 453-454
23. Tamura K., Nakajima H., Rakue H., Sasame A., Naito Y., Nagai Y., et al. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 63 5 (1999) 357-361
24. Yin R., Feng J., and Yao Z. Dynamic changes of serum vascular endothelial growth factor levels in a rat myocardial infarction model. Chin Med Sci J 15 3 (2000) 154-156
25. 125I-labeled basic fibroblast growth factor favor intramyocardial delivery. JACC. Presented at the 49th meeting of the American College of Cardiology, Anaheim, CA 35 (2000) 10A
26. Rakue H., Nakajima H., Katoh T., Usui M., Amemiya T., Miyagi M., et al. Low-dose basic fibroblast growth factor and vascular endothelial growth factor for angiogenesis in canine acute hindlimb insufficiency. Jpn Circ J 62 12 (1998) 933-939
27. Biswas S., Hughes G., Scarborough J., Domkowski P., Diodato L., Smith M., et al. Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: a comparative study. J Thorac Cardiovasc Surg 127 1 (2004) 34-43
28. 121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100 5 (1999) 468-474
29. Vale P., Losordo D., Milliken C., McDonald M., Gravelin L., Curry C., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103 17 (2001) 2138-2143
30. Rivard A., Silver M., Chen D., Kearney M., Magner M., Annex B., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154 2 (1999) 355-363
31. Couffinhal T., Silver M., Kearney M., Sullivan A., Witzenbichler B., Magner M., et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 99 24 (1999) 3188-3198
32. Schultz A., Lavie L., Hochberg I., Beyar R., Stone T., Skorecki K., et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 100 5 (1999) 547-552
33. Rivard A., Fabre J.-E., Silver M., Chen D., Murohara T., Kearney M., et al. Age-dependent impairment of angiogenesis. Circulation 99 1 (1999) 111-120
34. Schaper W., and Ito W. Molecular mechanisms of coronary collateral vessel growth. Circ Res 79 (1996) 911-919
35. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 14 (1999) 3964-3972
36. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., et al. Vascular endothelial growth factor 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 12 (2000) 1198-1202
37. Lazarous D., Scheinowitz M., Shou M., Hodge E., Rajanayagam S., Hunsberger S., et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91 1 (1995) 145-153
38. Lazarous D., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94 5 (1996) 1074-1082